Management of Chronic Hepatitis B Infection in India

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Chronic hepatitis B (CHB) infection presents a significant global health challenge, with India situated in an intermediate endemicity zone.
• Horizontal transmission and genotypes A and D are prevalent in India, contributing to substantial health and economic burdens.
• Existing CHB management guidelines are influenced by diverse factors including prevalence, awareness, resources, and HBV genotypes.

Purpose of the Study:

• To present expert recommendations for the management of CHB in India.
• To emphasize optimal strategies for treatment initiation, monitoring, and termination, particularly for borderline cases.
• To address challenges in CHB management and propose preferred therapeutic approaches tailored to the Indian context.

Main Methods:

• Review of existing literature and expert consensus on CHB management.
• Analysis of factors influencing CHB treatment strategies in India.
• Development of recommendations based on the Indian epidemiological profile and healthcare landscape.

Main Results:

• Expert-driven recommendations for CHB treatment initiation, monitoring, and termination are outlined.
• Specific attention is given to managing borderline cases and addressing unique challenges in the Indian setting.
• Preferred therapeutic approaches considering the Indian perspective are detailed.

Conclusions:

• Optimizing CHB management in India requires tailored strategies considering local factors and expert recommendations.
• Addressing challenges in disease awareness, resource availability, and genotype prevalence is crucial for effective CHB control.
• The article provides a framework for improved CHB patient care and outcomes in India.